MANSFIELD, MA — Mansfield BioIncubator proudly announces the first cohort of startups selected for the Fourth BIOINC Pitch-to-Portfolio Competition, awarding $80,000 in prizes on November 13, 2025.
Six BIOINC member companies have advanced through the qualification round and will compete across therapeutics, devices, diagnostics, and digital health:
· Modunai Therapeutics — Disarming cancer resistance with first-in-class bispecifics and ADCs targeting stress pathways
· Alnivo Therapeutics — Unlocking the therapeutic potential of HSP70 in regeneration and repair
· Diopter Technologies — BioShare biopolymer amniotic membrane lens for ocular surface disease
· AlphaCure Therapeutics — Precision radioligand therapy to cure cancer
· DeepCovalent — One-step drug discovery
· Liseva Bio — Turning therapeutic cells into resilient cell medicines
Additional contestants will be added pending final qualification.
Each participant will deliver a 5-minute investor-focused pitch, gaining visibility, mentorship, and access to BIOINC’s borderless life-science ecosystem — designed to accelerate startup success and investor engagement.
Brown University Partnership
This year’s event features a new collaboration with Brown University, which will present five graduate-level biotech venture teams in a rapid-fire elevator-pitch format. These student-led ventures, developed through Brown’s advanced biotechnology management program, represent investment-ready concepts supported by early technical validation and market analysis.
Judging Panel
The competition will be evaluated by an all-investor panel, including:
David Fogel, Managing Director, Swifton
Jeff Berman, Co-Founder, Big Tree Innovation Fund
Stacy Swider, MassVentures
Danielle O’Neal, Life Sciences, Banc of California
Luke Diehl, Longshot Ventures
Michael Partridge, Macpherson Capital Advisors
“The diversity of this year’s competitors — along with the global footprint of participating startups — highlights the continued growth of our life-science ecosystem,” said Russ Yukhananov, President of Mansfield Bio-Incubator. “This event provides emerging companies with visibility, expert mentorship, valuable investor connections, and a pathway to funding.”
To attend or request more information, contact: Alex Shlyankevich, PhD — Director of Investments📧 alexsh@bioinc.org
About Mansfield BioIncubator
Mansfield BIOINC supports early-stage life-science companies through mentoring programs, pitch competitions, investor access, networking, and state-of-the-art lab and office facilities. Its mission is to foster innovation in healthcare by accelerating startup growth and success.
241 Francis Ave, Mansfield, MA 02048
📧 info@bioinc.org